Tuberculosis Research Today is a free monthly online journal that collates and summarizes the latest research about Tuberculosis, including details on symptoms, causes, treatment, pulmonary, mycobacterium.

Volume 2 (2005), Issue 4 (April)

1. CD20-negative pyothorax-associated B cell lymphoma.
   Acta Haematol, 113(2): 144-5. [Abstract] [Full-text]
2. Low plasma selenium concentrations, high plasma human immunodeficiency virus load and high interleukin-6 concentrations are risk factors associated with anemia in adults presenting with pulmonary tuberculosis in Zomba district, Malawi.
   Eur J Clin Nutr, 59(4): 526-32. [Abstract] [Full-text]
3. Ocular tuberculosis in acquired immune deficiency syndrome (AIDS).
   Ocul Immunol Inflamm, 13(1): 87-9. [Abstract] [Full-text]
4. Endoretinal biopsy in establishing the diagnosis of uveitis: a clinicopathologic report of three cases.
   Ocul Immunol Inflamm, 13(1): 79-83. [Abstract] [Full-text]
5. Frequency and effective treatment of ulcers and sinuses in cases of tuberculous cervical lymphadenitis.
   J Coll Physicians Surg Pak, 15(3): 157-9. [Abstract] [Full-text]
6. Thyroid gland tuberculosis with endolaryngeal extension: a case with laryngotracheal dyspnoea.
   J Laryngol Otol, 119(1): 54-6. [Abstract] [Full-text]
7. Co-infection with HIV and TB: double trouble.
   Int J STD AIDS, 16(2): 95-100; quiz 101. [Abstract] [Full-text]
8. High risk of Mycobacterium tuberculosis infection during the Hajj pilgrimage.
   Trop Med Int Health, 10(4): 336-9. [Abstract] [Full-text]
9. Rural poverty and delayed presentation to tuberculosis services in Ethiopia.
   Trop Med Int Health, 10(4): 330-5. [Abstract] [Full-text]
10. Changes in the geographical distribution of tuberculosis patients in Veracruz, Mexico, after reinforcement of a tuberculosis control programme.
    Trop Med Int Health, 10(4): 305-11. [Abstract] [Full-text]
11. Metastatic tuberculous abscesses in an immunocompetent patient.
    Clin Exp Dermatol, 30(3): 247-9. [Abstract] [Full-text]
12. Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis.
    Nat Med, 11(4): S33-44. [Abstract] [Full-text]
13. Does DOTS work in populations with drug-resistant tuberculosis?
    Lancet, 365(9466): 1239-45. [Abstract] [Full-text]
14. Ipr1 gene mediates innate immunity to tuberculosis.
    Nature, 434(7034): 767-72. [Abstract] [Full-text]
15. Analysis of Mycobacterium tuberculosis genotypes in Madrid and identification of two new families specific to Spain-related settings.
    J Clin Microbiol, 43(4): 1797-806. [Abstract] [Full-text]
16. Use of an electronic nose to diagnose Mycobacterium bovis infection in badgers and cattle.
    J Clin Microbiol, 43(4): 1745-51. [Abstract] [Full-text]
17. Genetic diversity, determined on the basis of katG463 and gyrA95 polymorphisms, Spoligotyping, and IS6110 typing, of Mycobacterium tuberculosis complex isolates from Italy.
    J Clin Microbiol, 43(4): 1617-24. [Abstract] [Full-text]
18. Comparison of an internally controlled, large-volume LightCycler assay for detection of Mycobacterium tuberculosis in clinical samples with the COBAS AMPLICOR assay.
    J Clin Microbiol, 43(4): 1564-9. [Abstract] [Full-text]
19. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis.
    Clin Diagn Lab Immunol, 12(4): 491-6. [Abstract] [Full-text]
20. Adverse events and treatment completion for latent tuberculosis in jail inmates and homeless persons.
    Chest, 127(4): 1296-303. [Abstract] [Full-text]
21. Tuberculosis during fundamental societal changes in Estonia with special reference to extrapulmonary manifestations.
    Chest, 127(4): 1289-95. [Abstract] [Full-text]
22. Clinical, colonoscopic, and histological profile of colonic tuberculosis in a tertiary hospital.
    Endoscopy, 37(4): 351-6. [Abstract] [Full-text]
23. Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer.
    Respiration, 72(2): 166-75. [Abstract] [Full-text]
24. Tuberculous effusion: ADA activity correlates with CD4+ cell numbers in the fluid and the pleura.
    Respiration, 72(2): 160-5. [Abstract] [Full-text]
25. A new parameter in the detection of tuberculosis activity: reactive oxygen metabolites.
    Respiration, 72(2): 156-9. [Abstract] [Full-text]
26. Immunogenicity of mycobacterial PPE44 (Rv2770c) in Mycobacterium bovis BCG-infected mice.
    J Med Microbiol, 54: 443-8. [Abstract] [Full-text]
27. Delayed response to anti-tuberculosis treatment in a patient on infliximab.
    Respir Med, 99(5): 648-52. [Abstract] [Full-text]
28. Rounded atelectasis of the lung.
    Respir Med, 99(5): 615-23. [Abstract] [Full-text]
29. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection.
    Microbes Infect, 7(1): 1-8. [Abstract] [Full-text]
30. The magic bullets and tuberculosis drug targets.
    Annu Rev Pharmacol Toxicol, 45: 529-64. [Abstract] [Full-text]
31. Infection-induced apoptosis deletes bystander CD4+ T cells: a mechanism for suppression of autoimmunity during BCG infection.
    J Autoimmun, 24(2): 93-100. [Abstract] [Full-text]
32. Transcriptome profiling of adult zebrafish at the late stage of chronic tuberculosis due to Mycobacterium marinum infection.
    Mol Immunol, 42(10): 1185-203. [Abstract] [Full-text]
33. Adult lupus-prone MRL/MpJ2+ mice express a primary antibody repertoire that differs in CDR-H3 length distribution and hydrophobicity from that expressed in the C3H parental strain.
    Mol Immunol, 42(7): 789-98. [Abstract] [Full-text]
34. Vocal fold palsy due to plombage for tuberculosis.
    J Laryngol Otol, 119(2): 138-9. [Abstract] [Full-text]
35. The global alliance for tuberculosis drug development--accomplishments and future directions.
    Clin Chest Med, 26(2): 341-7, vii. [Abstract] [Full-text]
36. New drugs for tuberculosis: current status and future prospects.
    Clin Chest Med, 26(2): 327-40, vii. [Abstract] [Full-text]
37. Treatment of latent tuberculosis infection: challenges and prospects.
    Clin Chest Med, 26(2): 313-26, vii. [Abstract] [Full-text]
38. Tuberculosis in children.
    Clin Chest Med, 26(2): 295-312, vii. [Abstract] [Full-text]
39. Issues in the management of HIV-related tuberculosis.
    Clin Chest Med, 26(2): 283-94, vi-vii. [Abstract] [Full-text]
40. Treatment of active tuberculosis: challenges and prospects.
    Clin Chest Med, 26(2): 273-82, vi. [Abstract] [Full-text]
41. The diagnosis of tuberculosis.
    Clin Chest Med, 26(2): 247-71, vi. [Abstract] [Full-text]
42. Genetic susceptibility to tuberculosis.
    Clin Chest Med, 26(2): 233-46, vi. [Abstract] [Full-text]
43. Molecular epidemiology: a tool for understanding control of tuberculosis transmission.
    Clin Chest Med, 26(2): 217-31, vi. [Abstract] [Full-text]
44. The DOTS strategy for controlling the global tuberculosis epidemic.
    Clin Chest Med, 26(2): 197-205, v. [Abstract] [Full-text]
45. Epidemiology of tuberculosis in the United States.
    Clin Chest Med, 26(2): 183-95, v. [Abstract] [Full-text]
46. Global epidemiology of tuberculosis.
    Clin Chest Med, 26(2): 167-82, v. [Abstract] [Full-text]
47. Systemic AA-amyloidosis in a European wild boar (Sus scrofa) suffering from generalized tuberculosis.
    J Vet Med A Physiol Pathol Clin Med, 52(3): 135-7. [Abstract] [Full-text]
48. Mycobacterium tuberculosis inducing disseminated intravascular coagulation.
    Thromb Haemost, 93(4): 729-34. [Abstract] [Full-text]
49. Tuberculous peritonitis in no risk patients: diagnostic approach.
    ANZ J Surg, 75(4): 247-8. [Abstract] [Full-text]
50. T-helper cell intrinsic defects in lupus that break peripheral tolerance to nuclear autoantigens.
    J Mol Med, 83(4): 267-78. [Abstract] [Full-text]
51. Photo-onycholysis due to sparfloxacin.
    Australas J Dermatol, 46(2): 104-5. [Abstract] [Full-text]
52. Papular eruption on a tattoo: a case of primary inoculation tuberculosis.
    Australas J Dermatol, 46(2): 84-7. [Abstract] [Full-text]
53. Tuberculosis of the craniocervical junction: a case report.
    Zentralbl Neurochir, 66(2): 95-7. [Abstract] [Full-text]
54. The purinergic P2X7 receptor is not required for control of pulmonary Mycobacterium tuberculosis infection.
    Infect Immun, 73(5): 3192-5. [Abstract] [Full-text]
55. Induction of Mycobacterium tuberculosis-specific primary and secondary T-cell responses in interleukin-15-deficient mice.
    Infect Immun, 73(5): 2910-22. [Abstract] [Full-text]
56. Zoonotic aspects of Mycobacterium bovis and Mycobacterium avium-intracellulare complex (MAC).
    Vet Res, 36(3): 411-36. [Abstract] [Full-text]
57. Complex pulmonary aspergilloma treated with single stage cavernostomy and myoplasty.
    Eur J Cardiothorac Surg, 27(5): 737-40. [Abstract] [Full-text]
58. The roles of HRCT and clinical parameters in assessing activity of suspected smear negative pulmonary tuberculosis.
    Arch Med Res, 36(2): 166-70. [Abstract] [Full-text]
59. Disseminated extrapulmonary tuberculosis revealed by humeral osteomyelitis with chronic unremarkable pain.
    Joint Bone Spine, 72(3): 263-6. [Abstract] [Full-text]
60. Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis.
    Tuberculosis (Edinb), 85(3): 185-95. [Abstract] [Full-text]
61. An assay to compare the infectivity of Mycobacterium tuberculosis isolates based on aerosol infection of guinea pigs and assessment of bacteriology.
    Tuberculosis (Edinb), 85(3): 177-84. [Abstract] [Full-text]
62. Cell wall lipids from Mycobacterium bovis BCG are inflammatory when inoculated within a gel matrix: characterization of a new model of the granulomatous response to mycobacterial components.
    Tuberculosis (Edinb), 85(3): 159-76. [Abstract] [Full-text]
63. Sensitivity of human gamma interferon assay and tuberculin skin testing for detecting infection with Mycobacterium tuberculosis in patients with culture positive tuberculosis.
    Tuberculosis (Edinb), 85(3): 137-45. [Abstract] [Full-text]
64. Mycobacterium tuberculosis lineage: a naming of the parts.
    Tuberculosis (Edinb), 85(3): 127-36. [Abstract] [Full-text]
65. Clinical utility of lipoarabinomannan antibody in pleural fluid for the diagnosis of tuberculous pleurisy.
    J Infect Chemother, 11(2): 81-3. [Abstract] [Full-text]
66. Tuberculosis among American Indians and Alaska Natives in the United States, 1993-2002.
    Am J Public Health, 95(5): 873-80. [Abstract] [Full-text]
67. Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis.
    Vaccine, 23(27): 3581-9. [Abstract] [Full-text]
68. Segmental colonoscopic biopsies in the differentiation of ileocolic tuberculosis from Crohn's disease.
    J Gastroenterol Hepatol, 20(5): 688-96. [Abstract] [Full-text]
69. Tuberculous mastitis.
    J Coll Physicians Surg Pak, 15(4): 234-7. [Abstract] [Full-text]
70. Perianal ulceration: a case of tuberculosis cutis orificialis.
    J Eur Acad Dermatol Venereol, 19(3): 364-6. [Abstract] [Full-text]
71. Corneal endothelial deposits associated with rifabutin use.
    J Ocul Pharmacol Ther, 21(2): 166-9. [Abstract] [Full-text]
72. A patient with insidious onset of exertional dyspnoea.
    Thorax, 60(5): 437-8. [Abstract] [Full-text]
73. Th0 to Th1 switch of CD4 T cell clones specific from the 16-kDa antigen of Mycobacterium tuberculosis after successful therapy: lack of involvement of epitope repertoire and HLA-DR.
    Immunol Lett, 98(2): 253-8. [Abstract] [Full-text]
74. Risk factors for tuberculosis among inmates: a retrospective analysis.
    Public Health Nurs, 22(2): 108-18. [Abstract] [Full-text]

© 2004-2008 Tuberculosis Research Today. All Rights Reserved.